XML 69 R40.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Share-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Payment Arrangement [Abstract] |
Schedule of Compensation Expense and Related Income Tax Benefit | The compensation expense from the Company’s share-based compensation plans and associated income tax benefit, excluding the effects of excess tax benefits or shortfalls, were included in the Consolidated Statements of Operations as follows (in millions):
| Year Ended December 31,
Compensation costs and related income tax benefit | 2021 |  | 2020 |  | 2019
Cost of sales | $ | 8 |  |  | $ | 6 |  |  | $ | 4 |
Selling and marketing | 26 |  |  | 16 |  |  | 17 |
Research and development | 28 |  |  | 16 |  |  | 16 |
General and administration | 31 |  |  | 21 |  |  | 23 |
Total compensation expense | $ | 93 |  |  | $ | 59 |  |  | $ | 60 |
Income tax benefit | $ | 14 |  |  | $ | 9 |  |  | $ | 9 |
Summary of Equity Awards Activity | A summary of the Company’s restricted and performance stock-settled awards for the years ended December 31, 2021, 2020 and 2019 is as follows:
|  | Year Ended December 31, 2021
|  | RSUs |  | PSUs |  | RSAs |  | PSAs
|  | Units |  | Weighted-Average Grant Date Fair Value |  | Units |  | Weighted-Average Grant Date Fair Value |  | Shares |  | Weighted-Average Grant Date Fair Value |  | Shares |  | Weighted-Average Grant Date Fair Value
Outstanding at beginning of year |  | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | 318,565 |  |  | $ | 228.08 |  |  | 126,022 |  |  | $ | 199.77 |
Granted |  | 134,419 |  |  | 518.39 |  |  | 38,393 |  |  | 482.42 |  |  | 6,005 |  |  | 486.02 |  |  | — |  |  | — |
Released |  | (674) |  |  | 489.16 |  |  | — |  |  | — |  |  | (159,702) |  |  | 212.33 |  |  | (49,236) |  |  | 160.11 |
Forfeited |  | (3,736) |  |  | 509.58 |  |  | (702) |  |  | 482.42 |  |  | (10,546) |  |  | 239.78 |  |  | (2,754) |  |  | 236.18 |
Outstanding at end of year |  | 130,009 |  |  | $ | 518.80 |  |  | 37,691 |  |  | $ | 482.42 |  |  | 154,322 |  |  | $ | 253.54 |  |  | 74,032 |  |  | $ | 225.34 |
|  |  |  |  |  |  |  |  |  | Year Ended December 31, 2020
|  |  |  |  |  | RSAs |  | PSAs
|  |  |  |  |  |  |  |  |  | Shares |  | Weighted-Average Grant Date Fair Value |  | Shares |  | Weighted-Average Grant Date Fair Value
Outstanding at beginning of year |  |  |  |  |  |  |  |  |  | 434,641 |  |  | $ | 151.52 |  |  | 170,749 |  |  | $ | 144.47 |
Granted |  |  |  |  |  |  |  |  |  | 178,150 |  |  | 265.06 |  |  | 98,820 |  |  | 239.79 |
Released |  |  |  |  |  |  |  |  |  | (275,318) |  |  | 133.43 |  |  | (131,943) |  |  | 160.18 |
Forfeited |  |  |  |  |  |  |  |  |  | (18,908) |  |  | 199.04 |  |  | (11,604) |  |  | 194.23 |
Outstanding at end of year |  |  |  |  |  |  |  |  |  | 318,565 |  |  | $ | 228.08 |  |  | 126,022 |  |  | $ | 199.77 |
|  |  |  |  |  |  |  |  |  | Year Ended December 31, 2019
|  |  |  |  |  | RSAs |  | PSAs
|  |  |  |  |  |  |  |  |  | Shares |  | Weighted-Average Grant Date Fair Value |  | Shares |  | Weighted-Average Grant Date Fair Value
Outstanding at beginning of year |  |  |  |  |  |  |  |  |  | 657,724 |  |  | $ | 93.45 |  |  | 259,727 |  |  | $ | 86.41 |
Granted |  |  |  |  |  |  |  |  |  | 170,502 |  |  | 204.26 |  |  | 150,224 |  |  | 206.04 |
Released |  |  |  |  |  |  |  |  |  | (372,075) |  |  | 73.71 |  |  | (231,513) |  |  | 120.86 |
Forfeited |  |  |  |  |  |  |  |  |  | (21,510) |  |  | 141.29 |  |  | (7,689) |  |  | 102.42 |
Outstanding at end of year |  |  |  |  |  |  |  |  |  | 434,641 |  |  | $ | 151.52 |  |  | 170,749 |  |  | $ | 144.47 |
Summary of SARs Activity | A summary of the Company’s SARs is as follows:
| 2021 |  | 2020 |  | 2019
SARs | SARs |  | Weighted-Average Grant Date Exercise Price |  | SARs |  | Weighted-Average Grant Date Exercise Price |  | SARs |  | Weighted-Average Grant Date Exercise Price
Outstanding at beginning of year | 638,124 |  |  | $ | 113.98 |  |  | 896,923 |  |  | $ | 89.05 |  |  | 1,261,185 |  |  | $ | 75.71 |
Granted | — |  |  | — |  |  | 69,742 |  |  | 253.62 |  |  | 70,141 |  |  | 205.12 |
Exercised | (159,035) |  |  | 89.87 |  |  | (295,770) |  |  | 67.96 |  |  | (395,015) |  |  | 66.82 |
Forfeited | (4,938) |  |  | 213.80 |  |  | (31,193) |  |  | 149.09 |  |  | (39,388) |  |  | 92.72 |
Expired | — |  |  | — |  |  | (1,578) |  |  | 166.52 |  |  | — |  |  | — |
Outstanding at end of year | 474,151 |  |  | $ | 121.05 |  |  | 638,124 |  |  | $ | 113.98 |  |  | 896,923 |  |  | $ | 89.05 |
Exercisable at end of year | 383,273 |  |  | $ | 97.29 |  |  | 417,856 |  |  | $ | 81.88 |  |  | 489,357 |  |  | $ | 70.37 |
Summary of Information for SARs Outstanding | The following table summarizes information about SARs outstanding as of December 31, 2021:
| Outstanding |  | Exercisable
Aggregate intrinsic value (in millions) | $ | 225 |  | $ | 191
Weighted-average remaining contractual life (in years) | 3.6 |  | 3.3
Summary of Outstanding and Exercisable Options | A summary of the Reflexis Replacement Options outstanding is as follows:
| 2021 |  | 2020
Reflexis Replacement Options | Options |  | Weighted-Average Exercise Price |  | Options |  | Weighted-Average Exercise Price
Outstanding at beginning of year | 34,424 |  |  | $ | 58.09 |  |  | — |  |  | $ | — |
Granted | — |  |  | — |  |  | 38,228 |  |  | 57.82 |
Exercised | (9,318) |  |  | 59.68 |  |  | (3,408) |  |  | 55.79 |
Forfeited | (1,529) |  |  | 63.01 |  |  | (396) |  |  | 52.14 |
Outstanding at end of year | 23,577 |  |  | $ | 57.06 |  |  | 34,424 |  |  | $ | 58.09 |
Exercisable at end of year | 18,232 |  |  | $ | 54.50 |  |  | 6,716 |  |  | $ | 56.77 |
The following table summarizes information related to the Reflexis Replacement Options outstanding as of December 31, 2021:
| Outstanding |  | Exercisable
Aggregate intrinsic value (in millions) | $ | 13 |  |  | $ | 10
Weighted-average remaining contractual life (in years) | 6.3 |  | 5.9

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -URI http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration